- Home
- KNDI vs MNOV Comparison
KNDI vs MNOV Comparison
Compare KNDI & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNDI
- MNOV
- Stock Information
- Founded
- KNDI 2002
- MNOV 2000
- Country
- KNDI China
- MNOV United States
- Employees
- KNDI N/A
- MNOV N/A
- Industry
- KNDI Auto Manufacturing
- MNOV Biotechnology: Pharmaceutical Preparations
- Sector
- KNDI Consumer Discretionary
- MNOV Health Care
- Exchange
- KNDI Nasdaq
- MNOV Nasdaq
- Market Cap
- KNDI 96.3M
- MNOV 68.2M
- IPO Year
- KNDI N/A
- MNOV 2005
- Fundamental
- Price
- KNDI $1.12
- MNOV $1.32
- Analyst Decision
- KNDI
- MNOV Strong Buy
- Analyst Count
- KNDI 0
- MNOV 2
- Target Price
- KNDI N/A
- MNOV $7.00
- AVG Volume (30 Days)
- KNDI 90.2K
- MNOV 13.0K
- Earning Date
- KNDI 08-15-2025
- MNOV 08-07-2025
- Dividend Yield
- KNDI N/A
- MNOV N/A
- EPS Growth
- KNDI N/A
- MNOV N/A
- EPS
- KNDI N/A
- MNOV N/A
- Revenue
- KNDI $127,569,613.00
- MNOV N/A
- Revenue This Year
- KNDI N/A
- MNOV N/A
- Revenue Next Year
- KNDI N/A
- MNOV N/A
- P/E Ratio
- KNDI N/A
- MNOV N/A
- Revenue Growth
- KNDI 3.21
- MNOV N/A
- 52 Week Low
- KNDI $0.89
- MNOV $1.12
- 52 Week High
- KNDI $2.25
- MNOV $2.55
- Technical
- Relative Strength Index (RSI)
- KNDI 54.92
- MNOV 45.64
- Support Level
- KNDI $1.06
- MNOV $1.32
- Resistance Level
- KNDI $1.16
- MNOV $1.38
- Average True Range (ATR)
- KNDI 0.07
- MNOV 0.05
- MACD
- KNDI 0.01
- MNOV 0.00
- Stochastic Oscillator
- KNDI 76.47
- MNOV 44.44
About KNDI Kandi Technologies Group Inc
Kandi Technologies Group Inc is engaged in developing, manufacturing, and commercializing fully electric vehicle products and related technologies. Its products mainly consist of EV parts, EV products, and off-road vehicles, including All-Terrain Vehicles (ATVs), UTVs, go-karts, electric scooters, electric self-balancing scooters, and associated parts, and Lithium-ion cells, etc. The company generates maximum revenue from the sale of Off-road vehicles and associated parts. Geographically, it derives maximum revenue from the United States and other countries, followed by China.
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.